#VisualAbstract: Overall Survival Improved with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo...
Read MoreMay 4, 2024
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo...
Read MoreMay 1, 2024
1. In this randomized-controlled trial, two 12-day courses of teplizumab improved C-peptide levels...
Read MoreApr 26, 2024
Click to read the study in The New England Journal of Medicine ©2024 2 Minute Medicine, Inc. All...
Read MoreApr 26, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreApr 25, 2024
1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion...
Read MoreApr 24, 2024
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should...
Read MoreApr 20, 2024
Click here to read this study in JMIG. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreApr 19, 2024
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine,...
Read MoreApr 18, 2024
Click here to read this study in JAMA Cardiology. ©2024 2 Minute Medicine, Inc. All rights...
Read MoreApr 17, 2024
Click on the image to enlarge Click here to read this study in JAMA Network Open. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc....
Read MoreApr 13, 2024
1. Significantly more patients in the imetelstat group achieved RBC transfusion independence at 8...
Read MoreApr 12, 2024
Click to read the study in The New England Journal of Medicine ©2024 2 Minute Medicine, Inc. All...
Read MoreApr 12, 2024
1. Pazopanib did not improve disease-free survival in post-metastasectomy renal cell carcinoma...
Read MoreApr 11, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreApr 11, 2024
1. In two clinical trials, iptacopan in patients with paroxysmal nocturnal hemoglobinuria (PNH)...
Read MoreApr 6, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreApr 6, 2024
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read MoreApr 5, 2024
1. There were similar rates of ipsilateral invasive recurrence among the postoperative adjuvant...
Read MoreApr 4, 2024
1. For women with cervical intraepithelial neoplasia grade 2 (CIN2), the risk of preterm birth was...
Read MoreMar 27, 2024
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More